Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Y Graham

Showing results (121-130 of 481) with videos related to

Pageof 49
Sort By:
Gut|September 19, 2024
Commentary on: the management of patients with gastric intestinal metaplasiaDavid Y Graham, Yi-Chia Lee
Gut|November 9, 2021
Cross-roads for meta-analysis and network meta-analysis of <i>H. pylori</i> therapyDavid Y Graham, Ruben Hernaez, Theodore Rokkas
Nature Reviews. Gastroenterology & Hepatology|February 15, 2012
Clinical guidelines: Secondary prevention of gastric cancerMassimo Rugge, Matteo Fassan, David Y Graham
Therapeutic Advances in Gastroenterology|June 23, 2011
Diagnosis and management of iron deficiency anemia in the 21st centuryTerri D Johnson-Wimbley, David Y Graham
Internal Medicine (Tokyo, Japan)|April 8, 2010
Prevention of gastric cancer by Helicobacter pylori eradicationMasahiro Asaka, Mototsugu Kato, David Y Graham
Journal of Digestive Diseases|May 12, 2009
African, Asian or Indian enigma, the East Asian Helicobacter pylori: facts or medical mythsDavid Y Graham, Hong Lu, Yoshio Yamaoka
Japanese Journal of Helicobacter Research|January 3, 2017
Changing the natural history of metachronous gastric cancer after <i>H. pylori</i> eradicationDavid Y Graham, Satoko Matsueda, Akiko Shiotani
Gastroenterology|April 9, 2008
vacA i-region subtypingHiroaki Ogiwara, David Y Graham, Yoshio Yamaoka
Nature Clinical Practice. Gastroenterology & Hepatology|November 3, 2005
Is the use of COX-2 inhibitors in gastroenterology cost-effective?David Y Graham, Francis K L Chan
Current Opinion in Gastroenterology|October 13, 2005
Helicobacter pylori virulence factors: facts and fantasiesHong Lu, Yoshio Yamaoka, David Y Graham
Pageof 49

Showing results (121-130 of 481) with videos related to

Sort By:
Pageof 49
Gut|September 19, 2024
Commentary on: the management of patients with gastric intestinal metaplasiaDavid Y Graham, Yi-Chia Lee
Gut|November 9, 2021
Cross-roads for meta-analysis and network meta-analysis of <i>H. pylori</i> therapyDavid Y Graham, Ruben Hernaez, Theodore Rokkas
Nature Reviews. Gastroenterology & Hepatology|February 15, 2012
Clinical guidelines: Secondary prevention of gastric cancerMassimo Rugge, Matteo Fassan, David Y Graham
Therapeutic Advances in Gastroenterology|June 23, 2011
Diagnosis and management of iron deficiency anemia in the 21st centuryTerri D Johnson-Wimbley, David Y Graham
Internal Medicine (Tokyo, Japan)|April 8, 2010
Prevention of gastric cancer by Helicobacter pylori eradicationMasahiro Asaka, Mototsugu Kato, David Y Graham
Journal of Digestive Diseases|May 12, 2009
African, Asian or Indian enigma, the East Asian Helicobacter pylori: facts or medical mythsDavid Y Graham, Hong Lu, Yoshio Yamaoka
Japanese Journal of Helicobacter Research|January 3, 2017
Changing the natural history of metachronous gastric cancer after <i>H. pylori</i> eradicationDavid Y Graham, Satoko Matsueda, Akiko Shiotani
Gastroenterology|April 9, 2008
vacA i-region subtypingHiroaki Ogiwara, David Y Graham, Yoshio Yamaoka
Nature Clinical Practice. Gastroenterology & Hepatology|November 3, 2005
Is the use of COX-2 inhibitors in gastroenterology cost-effective?David Y Graham, Francis K L Chan
Current Opinion in Gastroenterology|October 13, 2005
Helicobacter pylori virulence factors: facts and fantasiesHong Lu, Yoshio Yamaoka, David Y Graham
Pageof 49